In a proof-of-principle experiment, we additionally showed that Itga4 (α4) KO in the human MM cell line, MM.1S, similarly led to decreased intramedullary tumor burden in the BM, and formation of extramedullary plasmacytomas relative to WT. This evidence concerns the gene ITGA4 and plasmacytoma.